146 related articles for article (PubMed ID: 36572567)
1.
Fagerholm U; Hellberg S; Alvarsson J; Spjuth O
Altern Lab Anim; 2023 Jan; 51(1):39-54. PubMed ID: 36572567
[TBL] [Abstract][Full Text] [Related]
2. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
3.
Fagerholm U; Hellberg S; Alvarsson J; Arvidsson McShane S; Spjuth O
Xenobiotica; 2021 Dec; 51(12):1366-1371. PubMed ID: 34845977
[TBL] [Abstract][Full Text] [Related]
4.
Fagerholm U; Hellberg S; Alvarsson J; Spjuth O
Xenobiotica; 2022 Feb; 52(2):113-118. PubMed ID: 35238270
[TBL] [Abstract][Full Text] [Related]
5. IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies.
Ahmad A; Pepin X; Aarons L; Wang Y; Darwich AS; Wood JM; Tannergren C; Karlsson E; Patterson C; Thörn H; Ruston L; Mattinson A; Carlert S; Berg S; Murphy D; Engman H; Laru J; Barker R; Flanagan T; Abrahamsson B; Budhdeo S; Franek F; Moir A; Hanisch G; Pathak SM; Turner D; Jamei M; Brown J; Good D; Vaidhyanathan S; Jackson C; Nicolas O; Beilles S; Nguefack JF; Louit G; Henrion L; Ollier C; Boulu L; Xu C; Heimbach T; Ren X; Lin W; Nguyen-Trung AT; Zhang J; He H; Wu F; Bolger MB; Mullin JM; van Osdol B; Szeto K; Korjamo T; Pappinen S; Tuunainen J; Zhu W; Xia B; Daublain P; Wong S; Varma MVS; Modi S; Schäfer KJ; Schmid K; Lloyd R; Patel A; Tistaert C; Bevernage J; Nguyen MA; Lindley D; Carr R; Rostami-Hodjegan A
Eur J Pharm Biopharm; 2020 Nov; 156():50-63. PubMed ID: 32805361
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.
Peters SA
Clin Pharmacokinet; 2008; 47(4):261-75. PubMed ID: 18336055
[TBL] [Abstract][Full Text] [Related]
7. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
Kosugi Y; Hosea N
Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
[TBL] [Abstract][Full Text] [Related]
8. Can We Predict Clinical Pharmacokinetics of Highly Lipophilic Compounds by Integration of Machine Learning or In Vitro Data into Physiologically Based Models? A Feasibility Study Based on 12 Development Compounds.
Parrott N; Manevski N; Olivares-Morales A
Mol Pharm; 2022 Nov; 19(11):3858-3868. PubMed ID: 36150125
[TBL] [Abstract][Full Text] [Related]
9. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Oral Pharmacokinetics Using a Combination of In Silico Descriptors and In Vitro ADME Properties.
Kosugi Y; Hosea N
Mol Pharm; 2021 Mar; 18(3):1071-1079. PubMed ID: 33512165
[TBL] [Abstract][Full Text] [Related]
11. In Silico Predictions of the Gastrointestinal Uptake of Macrocycles in Man Using Conformal Prediction Methodology.
Fagerholm U; Hellberg S; Alvarsson J; Spjuth O
J Pharm Sci; 2022 Sep; 111(9):2614-2619. PubMed ID: 35605685
[TBL] [Abstract][Full Text] [Related]
12. Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates - an evaluation and case study using GastroPlus.
Heikkinen AT; Baneyx G; Caruso A; Parrott N
Eur J Pharm Sci; 2012 Sep; 47(2):375-86. PubMed ID: 22759901
[TBL] [Abstract][Full Text] [Related]
13. truPK -- human pharmacokinetic models for quantitative ADME prediction.
Subramanian K
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):555-64. PubMed ID: 16863461
[TBL] [Abstract][Full Text] [Related]
14. Comparison between lab variability and
Fagerholm U; Spjuth O; Hellberg S
Xenobiotica; 2021 Oct; 51(10):1095-1100. PubMed ID: 34346291
[TBL] [Abstract][Full Text] [Related]
15. Prediction of human pharmacokinetics--gastrointestinal absorption.
Fagerholm U
J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
[TBL] [Abstract][Full Text] [Related]
16. Predicting Volume of Distribution in Humans: Performance of In Silico Methods for a Large Set of Structurally Diverse Clinical Compounds.
Murad N; Pasikanti KK; Madej BD; Minnich A; McComas JM; Crouch S; Polli JW; Weber AD
Drug Metab Dispos; 2021 Feb; 49(2):169-178. PubMed ID: 33239335
[TBL] [Abstract][Full Text] [Related]
17. Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds.
Zhang T; Heimbach T; Lin W; Zhang J; He H
J Pharm Sci; 2015 Sep; 104(9):2795-806. PubMed ID: 25690565
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Generic Methods to Predict Human Pharmacokinetics Using Physiologically Based Pharmacokinetic Model for Early Drug Discovery of Tyrosine Kinase Inhibitors.
Ren HC; Sai Y; Chen T
Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):121-132. PubMed ID: 30039459
[TBL] [Abstract][Full Text] [Related]
19. Advances in Predictions of Oral Bioavailability of Candidate Drugs in Man with New Machine Learning Methodology.
Fagerholm U; Hellberg S; Spjuth O
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925103
[TBL] [Abstract][Full Text] [Related]
20. Physiologically Based Biopharmaceutics Modeling of Regional and Colon Absorption in Dogs.
Eckernäs E; Tannergren C
Mol Pharm; 2021 Apr; 18(4):1699-1710. PubMed ID: 33720733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]